Angel Investor

• May 2022 - Present

VP Marketing

• Jul 2002 - Present

Zuventus Healthcare Ltd is today one of the top pharma companies in the country with Rs.1300 crores in turnover, 8 SBUs, and 3000 employees. However, my association with the company goes back to 2002 when the company was constituted. After being promoted to vice-president marketing, I was entrusted with marketing responsibilities of 2 major SBUS – One a multi-speciality, multi-therapeutic category & the other focusing on pain management. Envisioned and executed blueprints for both the SBUs resulting in a current turnover of Rs.900 crores. Our team has established three brands with Rs 100+ crores in sales and three with Rs.50+ crores in sales. A few completely new molecules were launched in both the SBUs. Sustained efforts of the team ensured that the company, for the first time, entered the vaccines and neuro-paediatric markets. Having spent such a long time in the industry, I am well-versed with challenges & opportunities that arise due to changing government policies. I have been responsible for anticipating such events and preparing each SBU for changing market conditions.

Visiting Faculty

• Jun 2019 - Present

Conducting lectures on Marketing for the students of PG Diploma in Chemical Technology Management. Conducting lectures on Marketing for the students of PG Diploma in Chemical Technology Management.

Marketing Manager

• Mar 2001 - Jul 2002

Leading the product management team of 7 members gave me the opportunity to replicate my earlier performance by increasing market share and introducing new brands. We orchestrated the launch of 17 new brands across categories including NSAIDs, antibiotics, nutrition, and cardiovasculars. The market share and turnover both doubled during the period, and the sales figures jumped from 28 crores to approximately 65 crores. Leading the product management team of 7 members gave me the opportunity to replicate my earlier performance by increasing market share and introducing new brands. We orchestrated the launch of 17 new brands across categories including NSAIDs, antibiotics, nutrition, and cardiovasculars. The market share and turnover both doubled during the period, and the sales figures jumped from 28 crores to approximately 65 crores.

Group Product Manager

• Jun 1999 - Feb 2001

After taking over the responsibilities as the Group Product Manager, the primary focus was on expanding Alkem into new segments. We introduced 10 new brands in cardiac and diabetic segments marking the entry of Alkem in the chronic segment. The efforts of the entire team paid off as two brands were in the top 5 brands in their respective categories. The marketing team followed a penetrative and innovative promotional approach also refreshing the identity of Alkem Ulticare. After taking over the responsibilities as the Group Product Manager, the primary focus was on expanding Alkem into new segments. We introduced 10 new brands in cardiac and diabetic segments marking the entry of Alkem in the chronic segment. The efforts of the entire team paid off as two brands were in the top 5 brands in their respective categories. The marketing team followed a penetrative and innovative promotional approach also refreshing the identity of Alkem Ulticare.

Senior Product Manager

• Oct 1997 - May 1999

I was entrusted with the responsibility of marketing Meftal and Tus-Q. Backed by a capable team, the brand was propelled with the introduction of newer extensions and fine-tuning the positioning & promotion of existing packs resulting in more than 20% growth.

Product Manager

• Mar 1997 - Sep 1997

Was part of the medical committee and new product development committee which worked towards the identification of newer molecules & therapeutic options.

Product Executive

• Sep 1996 - Feb 1997

Strategized for Ascoril syrup, launched Ascoril tablets, and planned for the revival of Scaboma. Strategized for Ascoril syrup, launched Ascoril tablets, and planned for the revival of Scaboma.

Product Executive

• Jun 1995 - Aug 1996

Managed M2-Tone and Livomyn contributing to more than 60% of the company turnover. Ensured successful launch of M2-Tone tablets. Managed M2-Tone and Livomyn contributing to more than 60% of the company turnover. Ensured successful launch of M2-Tone tablets.

Medical Representative

• Sep 1992 - May 1993

As a medical representative, learned the tricks of the trade from the experts and was even awarded “Best Overall Performance” at an in-house medical representative training program. Also, emerged as the highest productive medical representative for Softovac in Maharashtra. As a medical representative, learned the tricks of the trade from the experts and was even awarded “Best Overall Performance” at an in-house medical representative training program. Also, emerged as the highest productive medical representative for Softovac in Maharashtra.